Jan. 20 Medi-Cal Rx PA requirements reinstated for 39 drug classes

Provider Icon

Beginning Jan. 20, 2023, Medi-Cal Rx prior authorization (PA) requirements will be reinstated for 39 additional drug classes. Requirements apply to new start medications in these drug classes for beneficiaries 22 years of age and older.

Medi-Cal Rx Reinstatement – Phase II, Wave I Drug Classes
All Other Dermatologicals Corticotropins Other Antibiotics
Anabolics Emollients Protectives Other Hormones
Androgens Erythromycins Penicillins
Anesthetic Local Topical Estrogens Progesterone
Antiarthritics Fat Soluble Vitamins Streptomycins
Antifungals Folic Acid Preparations Sulfonamides
Antimalarials General Antibacterials and Antiseptics Systematic Contraceptives
Antiparasitics Glucocorticoids TB Preparations
Antiparkinson Iodine Therapy Tetracyclines
Anti-Ulcer Preps/Gastrointestinal Preps Multivitamins Thyroid Preps
Antivirals Muscle Relaxants Topical Nasal and Otic Preparations
Biologicals Non-Opioid Analgesics Urinary Antibacterials
Cephalosporins Ophthalmic Preparations Vitamin K

For full details, please review the Dec. 20 notification from DHCS. You can also keep up to date on Medi-Cal reinstatement on the Medi-Cal Rx Education and Outreach webpage.

Additional resources

Important upcoming dates

  • Feb. 24, 2023: PA requirements will be reinstated for all remaining Standard Therapeutic Classes (STCs) for beneficiaries 22 and older (Phase II, Wave 2).
  • March 24, 2023: DHCS will begin to lift transition policies that were in place for beneficiaries ages 22 years and older (Phase III).


Call the Medi-Cal Rx Customer Service Center at 800-977-2273 (available 24/7) days a week or email Medi-Cal Rx Education & Outreach at [email protected].